Terms: = Leukemia AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
465 results:
1. miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.
Cheng YC; Fan Z; Liang C; Peng CJ; Li Y; Wang LN; Luo JS; Zhang XL; Liu Y; Zhang LD
Technol Cancer Res Treat; 2024; 23():15330338241248576. PubMed ID: 38693824
[No Abstract] [Full Text] [Related]
2. Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid leukemia.
Jin D; Chen H; He J; Li Y; Zheng G; Yang Y; Zhao Y; Le J; Shu W; He D; Cai Z
Target Oncol; 2024 Mar; 19(2):237-249. PubMed ID: 38466536
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
[TBL] [Abstract] [Full Text] [Related]
4. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
[TBL] [Abstract] [Full Text] [Related]
5. Tumor necrosis factor α promotes clonal dominance of kit D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Greiner G; Witzeneder N; Klein K; Tangermann S; Kodajova P; Jaeger E; Ratzinger F; Gerner MC; Jawhar M; Baumgartner S; Fruehwirth K; Schmetterer KG; Zuber J; Gleixner KV; Mayerhofer M; Schwarzinger I; Simonitsch-Klupp I; Esterbauer H; Baer C; Walter W; Meggendorfer M; Strassl R; Haferlach T; Hartmann K; Kenner L; Sperr WR; Reiter A; Sexl V; Arock M; Valent P; Hoermann G
Blood; 2024 Mar; 143(11):1006-1017. PubMed ID: 38142424
[TBL] [Abstract] [Full Text] [Related]
6. kit exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
[TBL] [Abstract] [Full Text] [Related]
7. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
[TBL] [Abstract] [Full Text] [Related]
8. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Hidaka M; Inokuchi K; Uoshima N; Takahashi N; Yoshida N; Ota S; Nakamae H; Iwasaki H; Watanabe K; Kosaka Y; Komatsu N; Meguro K; Najima Y; Eto T; Kondo T; Kimura S; Yoshida C; Ishikawa Y; Sawa M; Hata T; Horibe K; Iida H; Shimomura T; Dobashi N; Sugiura I; Makiyama J; Miyagawa N; Sato A; Ito R; Matsumura I; Kanakura Y; Naoe T
Jpn J Clin Oncol; 2024 Feb; 54(2):153-159. PubMed ID: 37986553
[TBL] [Abstract] [Full Text] [Related]
9. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
[TBL] [Abstract] [Full Text] [Related]
10. Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
Valent P; Akin C; Arock M; Gleixner KV; Greinix H; Hermine O; Horny HP; Ivanov D; Orfao A; Rabitsch W; Reiter A; Schulenburg A; Sotlar K; Sperr WR; Ustun C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894806
[TBL] [Abstract] [Full Text] [Related]
11. Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways.
Li G; Yao J; Lu Z; Yu L; Chen Q; Ding L; Fang Z; Li Y; Xu B
Drugs R D; 2023 Dec; 23(4):439-451. PubMed ID: 37847357
[TBL] [Abstract] [Full Text] [Related]
12. [Characteristics of genetic variants in 134 patients with Acute myeloid leukemia].
He M; Zhao X; Tian H; Zhang S; Zhao F; Zhang X; Wu T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Oct; 40(10):1222-1227. PubMed ID: 37730221
[TBL] [Abstract] [Full Text] [Related]
13. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
[TBL] [Abstract] [Full Text] [Related]
14. Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications.
Panigrahi C; Tikare N; Das PK; Padhi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591621
[TBL] [Abstract] [Full Text] [Related]
15. Circ_0001602 aggravates the progression of acute myeloid leukemia by regulating the miR-192-5p/ZBTB20 axis.
Wu W; Deng J; Chen C; Ma X; Yu L; Chen L
Hematology; 2023 Dec; 28(1):2240133. PubMed ID: 37585722
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of
Fajami Z; Akbarin MM; Rafatpanah H; Ramezani S; Rahimi H; Rezaee SA
AIDS Res Hum Retroviruses; 2024 Mar; 40(3):141-147. PubMed ID: 37565279
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic leukemia.
Aref S; El Tantawy A; Gouda E; Ayed M
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
[TBL] [Abstract] [Full Text] [Related]
18. Arginine metabolism key enzymes affect the prognosis of myelodysplastic syndrome by interfering with macrophage polarization.
Ou Y; Yang Y; Li X; Zhang X; Zhao L; Yang C; Wu Y
Cancer Med; 2023 Aug; 12(15):16444-16454. PubMed ID: 37366304
[TBL] [Abstract] [Full Text] [Related]
19. Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
[TBL] [Abstract] [Full Text] [Related]
20. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2023 Jul; 98(7):1097-1116. PubMed ID: 37309222
[TBL] [Abstract] [Full Text] [Related]
[Next]
